Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shu-Ping Hsueh"'
Autor:
Shu-Ping Hsueh, 薛淑萍
100
Overexpression of HER2 has been frequently detected in many types of human cancer, most notably breast and ovarian cancers. HER2 overexpression is associated with increased angiogenesis, increased metastasis, increased chemoresistance and re
Overexpression of HER2 has been frequently detected in many types of human cancer, most notably breast and ovarian cancers. HER2 overexpression is associated with increased angiogenesis, increased metastasis, increased chemoresistance and re
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/57959984650785599184
Publikováno v:
Cancer Letters. 324:48-57
HER2-overexpressing cancer cells are resistant to cisplatin (CDDP) and doxorubicin (DXR). Here we report that SV40 T/t-common polypeptide could specifically sensitize HER2-overexpressing cancer cells to CDDP and DXR and specifically enhance CDDP- or
Autor:
Shu Ping Hsueh, 薛淑萍
102
The aim of the thesis is to investigate whether the overconfidence behavior impacts the M&;A decision making process and the performance of the M&;A activity, covering the M&;A data of Taiwan listed companies from 1995 to 2009. Taking the ch
The aim of the thesis is to investigate whether the overconfidence behavior impacts the M&;A decision making process and the performance of the M&;A activity, covering the M&;A data of Taiwan listed companies from 1995 to 2009. Taking the ch
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/49492533321456342506
Autor:
Pei-Jing Hsu, Chang-Shan Hsu, Shu-Ping Hsueh, Wei-hua Hao, Jong-Jing Wang, Kuang-Yang Hsu, Li-Chien Chang
Publikováno v:
Cancer chemotherapy and pharmacology. 71(2)
The chemotherapy agent gemcitabine is currently administered intravenously because the drug has poor oral bioavailability. In order to assess the pharmacokinetics and antitumor activity of D07001-F4, a new self-microemulsifying oral drug delivery sys
Publikováno v:
Cancer gene therapy. 18(12)
Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human ovarian cancers and its overexpression is associated with increased angiogenesis, increased metastasis and reduced survival. Inhibition of HER2 in HER2-overexpressin
Autor:
Hsiang-Ling Ho, Michael H. Silverman, Nashat Y. Gabrail, C.-Y. Huang, Chia-Li Lin, Shu-Ping Hsueh, Sharad A. Ghamande, Carrie Smith
Publikováno v:
Journal of Clinical Oncology. 33:e13537-e13537
e13537 Background: This open-label, phase 0, dose-escalation study of 3 successive cohorts was conducted to determine and characterize the plasma PK of D07001-F4, an oral formulation of gemcitabine...
Autor:
Jih-Hsiang Lee, Shu-Ping Hsueh, C.-Y. Huang, Chia-Li Lin, Chia-Chi Lin, James Chih-Hsin Yang, Hsiang-Ling Ho, Wu Chou Su, Chih-Hung Hsu, Ann-Lii Cheng
Publikováno v:
Journal of Clinical Oncology. 32:TPS2631-TPS2631
TPS2631^ Background: Gemcitabine HCl is a nucleoside analogue that exhibits antitumor activity and is approved for IV use in the world. Oral dosing of gemcitabine HCl would simplify administration ...
Publikováno v:
Molecular Cancer Therapeutics. 8:A195-A195
HER2 overexpression in various tumors results in increased angiogenesis, metastasis and reduced survival. Previously we reported that simian virus 40 T/t-common polypeptide can repress HER2 expression and specifically induce apoptosis in HER2-overexp